Pharmarise Holdings Corporation (2796.T)
JPY 563.0
(-2.26%)
JPY 563.0
(-2.26%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.08 Billion JPY | -22.6% |
| 2022 | 2.66 Billion JPY | -4.53% |
| 2021 | 2.82 Billion JPY | 7.95% |
| 2020 | 2.59 Billion JPY | 15.25% |
| 2019 | 2.26 Billion JPY | 23.65% |
| 2018 | 1.86 Billion JPY | -26.78% |
| 2017 | 2.5 Billion JPY | 43.86% |
| 2016 | 1.77 Billion JPY | -13.74% |
| 2015 | 2.38 Billion JPY | -13.45% |
| 2014 | 2.27 Billion JPY | -7.67% |
| 2013 | 2.44 Billion JPY | 12.69% |
| 2012 | 2.64 Billion JPY | -1.56% |
| 2011 | 2.24 Billion JPY | 9.54% |
| 2010 | 1.9 Billion JPY | 57.38% |
| 2009 | 1.12 Billion JPY | 49.01% |
| 2008 | 912.82 Million JPY | 12.23% |
| 2007 | 790.24 Million JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 345.5 Million JPY | 14.91% |
| 2023 Q2 | 386 Million JPY | 12.21% |
| 2023 Q1 | 344 Million JPY | -36.3% |
| 2023 Q4 | 355 Million JPY | -20.94% |
| 2023 Q3 | 449 Million JPY | 16.32% |
| 2023 FY | - JPY | -22.6% |
| 2022 Q3 | 339 Million JPY | 42.44% |
| 2022 FY | - JPY | -4.53% |
| 2022 Q1 | 354 Million JPY | -27.46% |
| 2022 Q2 | 238 Million JPY | -32.77% |
| 2022 Q4 | 540 Million JPY | 59.29% |
| 2021 Q4 | 488 Million JPY | 118.83% |
| 2021 Q3 | 223 Million JPY | -52.55% |
| 2021 Q2 | 470 Million JPY | 40.72% |
| 2021 Q1 | 334 Million JPY | -28.78% |
| 2021 FY | - JPY | 7.95% |
| 2020 Q2 | 552 Million JPY | 2660.0% |
| 2020 FY | - JPY | 15.25% |
| 2020 Q4 | 469 Million JPY | 87.6% |
| 2020 Q1 | 20 Million JPY | -92.51% |
| 2020 Q3 | 250 Million JPY | -54.71% |
| 2019 Q2 | 405 Million JPY | 216.41% |
| 2019 Q1 | 128 Million JPY | -64.93% |
| 2019 FY | - JPY | 23.65% |
| 2019 Q4 | 267 Million JPY | 10.79% |
| 2019 Q3 | 241 Million JPY | -40.49% |
| 2018 Q4 | 365 Million JPY | 234.86% |
| 2018 FY | - JPY | -26.78% |
| 2018 Q3 | 109 Million JPY | -28.29% |
| 2018 Q2 | 152 Million JPY | 1185.71% |
| 2018 Q1 | -14 Million JPY | -106.28% |
| 2017 FY | - JPY | 43.86% |
| 2017 Q3 | 376 Million JPY | -12.15% |
| 2017 Q1 | 153 Million JPY | -10.0% |
| 2017 Q2 | 428 Million JPY | 179.74% |
| 2017 Q4 | 223 Million JPY | -40.69% |
| 2016 Q3 | 92 Million JPY | -45.24% |
| 2016 Q1 | 19 Million JPY | -79.82% |
| 2016 Q2 | 168 Million JPY | 784.21% |
| 2016 Q4 | 170 Million JPY | 84.78% |
| 2016 FY | - JPY | -13.74% |
| 2015 Q2 | 300.76 Million JPY | 47.64% |
| 2015 FY | - JPY | -13.45% |
| 2015 Q1 | 203.71 Million JPY | -52.83% |
| 2015 Q4 | 94.16 Million JPY | -57.53% |
| 2015 Q3 | 221.74 Million JPY | -26.27% |
| 2014 Q3 | 240.15 Million JPY | -32.75% |
| 2014 Q4 | 431.86 Million JPY | 79.83% |
| 2014 Q2 | 357.07 Million JPY | 144.41% |
| 2014 Q1 | 146.09 Million JPY | -63.93% |
| 2014 FY | - JPY | -7.67% |
| 2013 Q2 | 344.71 Million JPY | -7.06% |
| 2013 Q3 | 324.84 Million JPY | -5.76% |
| 2013 FY | - JPY | 12.69% |
| 2013 Q4 | 405.04 Million JPY | 24.69% |
| 2013 Q1 | 370.92 Million JPY | -29.09% |
| 2012 Q3 | 310.32 Million JPY | 5.45% |
| 2012 Q2 | 294.28 Million JPY | 5.42% |
| 2012 Q1 | 279.15 Million JPY | -25.28% |
| 2012 FY | - JPY | -1.56% |
| 2012 Q4 | 523.06 Million JPY | 68.56% |
| 2011 Q4 | 373.57 Million JPY | -14.31% |
| 2011 FY | - JPY | 9.54% |
| 2011 Q2 | 393.79 Million JPY | -2.24% |
| 2011 Q3 | 435.96 Million JPY | 10.71% |
| 2011 Q1 | 402.81 Million JPY | -43.57% |
| 2010 Q3 | 479.14 Million JPY | -25.46% |
| 2010 Q4 | 713.8 Million JPY | 48.97% |
| 2010 FY | - JPY | 57.38% |
| 2010 Q1 | 244.07 Million JPY | -49.57% |
| 2010 Q2 | 642.82 Million JPY | 163.38% |
| 2009 Q2 | 290.21 Million JPY | 41.75% |
| 2009 Q3 | 342.6 Million JPY | 18.05% |
| 2009 FY | - JPY | 49.01% |
| 2009 Q1 | 204.73 Million JPY | -24.95% |
| 2009 Q4 | 483.95 Million JPY | 41.26% |
| 2008 Q3 | 290.71 Million JPY | 254.24% |
| 2008 FY | - JPY | 12.23% |
| 2008 Q2 | 82.06 Million JPY | 0.0% |
| 2008 Q4 | 272.79 Million JPY | -6.16% |
| 2007 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| HEARTSEED INC | -1.44 Billion JPY | 244.034% |
| Cawachi Limited | 11.85 Billion JPY | 82.4% |
| Qol Holdings Co., Ltd. | 14.21 Billion JPY | 85.321% |
| MatsukiyoCocokara & Co. | 98.01 Billion JPY | 97.872% |
| Welcia Holdings Co., Ltd. | 67.62 Billion JPY | 96.915% |
| Create SD Holdings Co., Ltd. | 24.34 Billion JPY | 91.433% |
| NIHON CHOUZAI Co.,Ltd. | 14.65 Billion JPY | 85.766% |
| COSMOS Pharmaceutical Corporation | 51.42 Billion JPY | 95.944% |
| Tsuruha Holdings Inc. | 67.2 Billion JPY | 96.896% |
| Ohki Healthcare Holdings Co.,Ltd. | 3.81 Billion JPY | 45.335% |
| Satudora Holdings Co.,Ltd. | 2.71 Billion JPY | 23.083% |
| Kusuri No Aoki Holdings Co., Ltd. | 30.64 Billion JPY | 93.192% |
| Medical System Network Co., Ltd. | 6.99 Billion JPY | 70.183% |
| Shinnihonseiyaku Co., Ltd. | 4.18 Billion JPY | 50.191% |
| Sugi Holdings Co.,Ltd. | 50.74 Billion JPY | 95.889% |
| YAKUODO HOLDINGS Co., Ltd. | 8.16 Billion JPY | 74.446% |
| Astena Holdings Co., Ltd. | 4.17 Billion JPY | 50.003% |
| Genky DrugStores Co., Ltd. | 14.47 Billion JPY | 85.588% |
| Ain Holdings Inc. | 31.22 Billion JPY | 93.319% |
| Sundrug Co.,Ltd. | 56.23 Billion JPY | 96.291% |